Vanguard Portfolio Management 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-31 11:39 am Purchase | 2026-06-30 | 13G | VIR BIOTECHNOLOGY INC VIR | Vanguard Portfolio Management | 11,554,377 6.850% | 2,297,142 (+24.81%) | Filing |
| 2026-04-29 3:50 pm Purchase | 2026-03-31 | 13G | VIR BIOTECHNOLOGY INC VIR | Vanguard Portfolio Management | 9,257,235 5.790% | 9,257,235 (New Position) | Filing |